132 related articles for article (PubMed ID: 33630017)
1. Medications in Single-Dose Vials and Implications of Discarded Injectable Drugs: A National Academies Report.
Shortliffe EH; Lyman GH; Amankwah FK
JAMA; 2021 Apr; 325(15):1507-1508. PubMed ID: 33630017
[No Abstract] [Full Text] [Related]
2. US drug shortages are set to reach record high in 2011, report says.
Tanne JH
BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
[No Abstract] [Full Text] [Related]
3. Conference sheds light on supply chain challenges.
Young D
Am J Health Syst Pharm; 2004 Sep; 61(17):1760-2, 1765. PubMed ID: 15462242
[No Abstract] [Full Text] [Related]
4. Oversight absent for double-billing on multi-use drug vials.
Carlson J
Mod Healthc; 2014 Jan; 44(2):8-9. PubMed ID: 24693742
[No Abstract] [Full Text] [Related]
5. Inaccuracy in the doses of injectable medications dispensed from rubber-stoppered vials.
Berger SA; Porat R; Gorea A
Eur J Clin Pharmacol; 1989; 37(1):91-4. PubMed ID: 2591471
[TBL] [Abstract][Full Text] [Related]
6. Paying for Cancer Drugs That Prove Their Benefit.
Frank RG; Emanuel EJ
JAMA; 2021 Oct; 326(16):1579-1580. PubMed ID: 34633420
[No Abstract] [Full Text] [Related]
7. Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007.
Meron D
Seton Hall Law Rev; 2007; 37(4):929-39. PubMed ID: 18363219
[No Abstract] [Full Text] [Related]
8. Rules and regulations. CMS addresses drug prices, payment rates.
Fong T
Mod Healthc; 2004 Aug; 34(31):8-9, 13. PubMed ID: 15332517
[No Abstract] [Full Text] [Related]
9. Pharmaceuticals and medical devices: cost savings.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
[No Abstract] [Full Text] [Related]
10. Pharmaceuticals: drug importation.
Seay M; Jones TM
Issue Brief Health Policy Track Serv; 2007 Jan; ():1-15. PubMed ID: 17361466
[No Abstract] [Full Text] [Related]
11. US agrees to cheap drug imports--as Florida officials break fake drugs ring.
Charatan F
BMJ; 2003 Aug; 327(7409):246. PubMed ID: 12896918
[No Abstract] [Full Text] [Related]
12. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
Werling K; Abraham S; Strelec J
J Health Care Finance; 2007; 34(2):57-70. PubMed ID: 18972994
[No Abstract] [Full Text] [Related]
13. Pharmaceuticals and medical devices: Medicare Part D.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2014 Dec; ():1-31. PubMed ID: 25771554
[No Abstract] [Full Text] [Related]
14. One pill, many prices: variation in prescription drug prices in selected government programs.
Gencarelli DM
Issue Brief George Wash Univ Natl Health Policy Forum; 2005 Aug; (807):1-20. PubMed ID: 16167399
[TBL] [Abstract][Full Text] [Related]
15. New rules for US drug reimbursement.
Bouchie A
Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382
[No Abstract] [Full Text] [Related]
16. A New Focus on Prescription Drug Spending.
Wilensky G
JAMA; 2015 Aug; 314(5):440-1. PubMed ID: 26241584
[No Abstract] [Full Text] [Related]
17. Specialty Drugs - A Distinctly American Phenomenon.
Naci H; Kesselheim AS
N Engl J Med; 2020 Jun; 382(23):2179-2181. PubMed ID: 32492301
[No Abstract] [Full Text] [Related]
18. Current and future state of FDA-CMS parallel reviews.
Messner DA; Tunis SR
Clin Pharmacol Ther; 2012 Mar; 91(3):383-5. PubMed ID: 22343814
[TBL] [Abstract][Full Text] [Related]
19. Hospitals' reimbursement woes continue with 2004 OPPS.
Traynor K
Am J Health Syst Pharm; 2003 Dec; 60(24):2536, 2538, 2540. PubMed ID: 14735768
[No Abstract] [Full Text] [Related]
20. Limiting State Flexibility in Drug Pricing.
Bagley N; Sachs RE
N Engl J Med; 2018 Sep; 379(11):1002-1004. PubMed ID: 30207910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
